First American Bank’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,333	Closed	-$204K	–	260
2020 Q4	$204K	Buy	+1,333	New	+$204K	0.01%	250
2018 Q4	–	Sell	-6,208	Closed	-$275K	–	317
2018 Q3	$275K	Buy	+6,208	New	+$275K	0.02%	297